Sergio Islas‐Andrade

Author

Also Known As

Cristina Revilla-Monsalve, Ma. Cristina Revilla-Monsalve, S Islas-Andrade, S. Islas-Andrade, S. Islas‐Andrade, S.A. Islas-Andrade, SERGIO ISLAS-ANDRADE, Sergio A. Islas-Andrade, Sergio Agustin Islas-Andrade, Sergio Islas-Andrade

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Mexican Social Security Institute Universidad Nacional Autónoma de México National Institute of Genomic Medicine Hospital General de México Centro Medico Nacional Siglo XXI

About

Sergio Islas‐Andrade is an author at Mexican Social Security Institute specializing in medicine, diabetes, and metabolic syndrome.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	566
2	Health Sciences	3	3	130
3	Public Health	3	3	139
4	Engineering	1	1	18
5	Biology	1	1	19

Sergio Islas‐Andrade

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Association of a Low-Frequency Variant in<i>HNF1A</i>With Type 2 Diabetes in a Latino Population Karol Estrada, Ingvild Aukrust, Lise Bjørkhaug, JAMA	2014	264
Type 2 Diabetes Variants Disrupt Function of SLC16A11 through Two Distinct Mechanisms Victor Rusu, Eitan Hoch, Josep M. Mercader, Cell Metabolic SyndromeDistinct MechanismsSignal TransductionGeneticsDiabetes	2017	155
Determinants of penetrance and variable expressivity in monogenic metabolic conditions across 77,184 exomes Julia K. Goodrich, Moriel Singer‐Berk, Rachel G. Son, Nature Communications	2021	102
Hypoglycemic effect of Cecropia obtusifolia Bertol aqueous extracts on type 2 diabetic patients M. Revilla, Adolfo Andrade‐Cetto, Miguel Angel Palomino-Garibay, Journal of Ethnopharmacology Diabetes ManagementBertol Aqueous ExtractsHerbal MedicineDiabetesType 2	2007	76
Rare coding variants in 35 genes associate with circulating lipid levels—A multi-ancestry analysis of 170,000 exomes George Hindy, Peter Dornbos, Mark Chaffin, The American Journal of Human Genetics Genome-wide Association StudyAllelic VariantHuman PhenotypesMedicineGenetics	2021	63
Prediabetes and its Relationship with Obesity in Mexican Adults: The Mexican Diabetes Prevention (MexDiab) Study Fernando Guerrero‐Romero, Martha Rodrı́guez-Morán, Ricardo Pérez-Fuentes, Metabolic Syndrome and Related Disorders	2008	58
Effects of biotin on pyruvate carboxylase, acetyl-CoA carboxylase, propionyl-CoA carboxylase, and markers for glucose and lipid homeostasis in type 2 diabetic patients and nondiabetic subjects Armida Báez‐Saldaña, Ivan R. Zendejas-Ruiz, M. Revilla, American Journal of Clinical Nutrition Metabolic SyndromeHealth SciencesPhysiologyDiabetesType 2	2004	58
Efficacy of glimepiride/metformin combination versus glibenclamide/metformin in patients with uncontrolled type 2 diabetes mellitus Manuel González-Ortı́z, Jesús Fernando Guerrero-Romero, Rafael Violante-Ortíz, Journal of Diabetes and its Complications Metabolic SyndromeDiabetes ManagementDiabetesPharmacologyUncontrolled Type 2	2008	49
Biotin supplementation reduces plasma triacylglycerol and VLDL in type 2 diabetic patients and in nondiabetic subjects with hypertriglyceridemia M. Revilla, Ivan R. Zendejas-Ruiz, Sergio Islas‐Andrade, Biomedicine & Pharmacotherapy Metabolic SyndromeDiabetes ManagementCardiovascular DiseaseDiabetesPhysiology	2006	48
Serum Levels of Interleukin-13 Increase in Subjects with Insulin Resistance but Do Not Correlate with Markers of Low-Grade Systemic Inflammation Camilo P. Martínez‐Reyes, Angélica Y. Gómez-Arauz, Israel Torres-Castro, Journal of Diabetes Research	2018	46

Page 1